Combination of Dolutegravir, Lamivudine Effective in People Living With HIV
The efficacy and tolerability of the 2-drug regimen of dolutegravir (DTG) and lamivudine (3TC) in individuals living with HIV was evaluated in a review published in Infectious Diseases and Therapy,1 confirming the results seen in phase 3 trials of the treatment. HIV causes immunosuppression because the virus attacks cells that usually fight infections. People living … Read more